Taho Pharmaceuticals Ltd. (TPEX:6467)
168.50
-0.50 (-0.30%)
At close: Oct 9, 2025
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 8.66 billion as of October 10, 2025. Its market cap has increased by 2,320.06% in one year.
Market Cap
8.66B
Enterprise Value
8.27B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
168.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 8.66B, an increase of 314.32%. That is a compound annual growth rate of 13.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 8.66B | 280.80% |
Dec 31, 2024 | 2.27B | 1,107.48% |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Taiwan Semiconductor Manufacturing Company | 37.34T |
Hon Hai Precision Industry | 3,076.68B |
Delta Electronics | 2,594.95B |
MediaTek | 2,143.75B |
Fubon Financial Holding | 1,257.86B |
Quanta Computer | 1,148.65B |
Chunghwa Telecom | 1,031.74B |
Cathay Financial Holding | 974.04B |